CFI Activators

CFI, or Complement Factor I, is a serum glycoprotein that plays a crucial role in the regulation of the complement system, which is an essential component of the innate immune response. The gene that encodes CFI is known as "CFI," and it is located on chromosome 4 in humans.CFI functions as a serine protease with a unique specificity for cleaving complement proteins C3b and C4b, which are central to the amplification of the complement cascade. By inactivating C3b and C4b, CFI downregulates the complement system, preventing excessive inflammation and damage to host tissues. This proteolytic activity requires the presence of cofactors such as complement factor H (CFH) or receptor 1 (CR1) on host cells, which bind to C3b or C4b and allow CFI to cleave these molecules.

The regulation of CFI activity is critical, as uncontrolled complement activation can lead to a variety of pathological conditions, including autoimmune diseases, age-related macular degeneration, and atypical hemolytic uremic syndrome. Moreover, mutations in the CFI gene may result in either reduced or dysfunctional CFI, leading to an increased risk of developing these diseases due to the inability to properly regulate the complement system.CFI is synthesized mainly in the liver and secreted into the bloodstream, where it circulates as a zymogen. Upon activation, it exhibits its protease activity, ensuring that the complement system remains finely balanced between protective immunity and pathological inflammation. The study of CFI has implications, as modulating its activity could provide a means to control the complement system in disease states characterized by complement dysregulation.